Post Thumbnail

Google releases TxGemma AI models for drug development

Google has announced the development of an innovative set of “open” AI models called TxGemma, designed to revolutionize the drug development process. The announcement was made on Tuesday during a healthcare-focused event in New York.

According to the company’s statement, the new AI models, which are planned to launch through the Health AI Developer Foundations program this month, have a unique ability to process both regular text and structures of various “therapeutic units,” including chemical compounds, molecules, and proteins.

“Developing therapeutic drugs from concept to approved use is a lengthy and costly process, so we are collaborating with the broader research community to find new ways to improve the efficiency of this process,” explained Karen DeSalvo, Google’s Chief Health Officer, in a blog post provided to TechCrunch. “Researchers will be able to ask TxGemma questions that help predict important properties of potential new therapies, such as their safety or efficacy.”

However, Google has not yet disclosed details about the licensing of these models, leaving open questions about the possibility of their commercial use, customization, and additional training. TechCrunch has reached out to the company for clarification and is awaiting a response.

Despite optimistic statements from many companies, including Google’s spin-off Isomorphic Labs, about the revolutionary potential of AI in drug development, the reality proves to be more complex. Although certain successes have been achieved, artificial intelligence has not yet become a magical solution for laboratory research.

Recent years have been marked by high-profile failures in clinical trials at companies using AI for drug development, including Exscientia and BenevolentAI. Moreover, the accuracy of leading AI systems in this field, such as Google DeepMind’s AlphaFold 3, demonstrates significant variability in results.

Autor: AIvengo
For 5 years I have been working with machine learning and artificial intelligence. And this field never ceases to amaze, inspire and interest me.
Latest News
AI chatbots generate content that exacerbates eating disorders

A joint study by Stanford University and the Center for Democracy and Technology showed a disturbing picture. Chatbots with artificial intelligence pose a serious risk to people with eating disorders. Scientists warn that neural networks hand out harmful advice about diets. They suggest ways to hide the disorder and generate "inspiring weight loss content" that worsens the problem.

OpenAGI released the Lux model that overtakes Google and OpenAI

Startup OpenAGI released the Lux model for computer control and claims this is a breakthrough. According to benchmarks, the model overtakes analogues from Google, OpenAI and Anthropic by a whole generation. Moreover, it works faster. About 1 second per step instead of 3 seconds for competitors. And 10 times cheaper in cost per processing 1 token.

Altman declared red alert at OpenAI due to Google's successes

Sam Altman declared "red alert level" at OpenAI, and this is not just corporate drama. This is an admission that the market leader felt competitors breathing down their neck. According to an internal memo, he is mobilizing additional resources to improve ChatGPT amid growing threats from Google.

Users spend more time with Gemini than with ChatGPT

OpenAI still leads in user numbers, but people are starting to spend more time with competitors. And this creates a serious problem.

Companies are bringing back 5% of those fired due to AI implementation failure

Many companies began bringing back employees fired because of artificial intelligence. Analytics company Visier studied employment data of 2.5 million employees from 142 companies worldwide. About 5% of fired employees subsequently returned to their previous employer. This indicator remained stable for several years, but recently began to rise.